PT1090033E - Particulas de proteinas de envelope do hcv: utilizacao para vacinacao - Google Patents

Particulas de proteinas de envelope do hcv: utilizacao para vacinacao

Info

Publication number: PT1090033E
Authority: PT; Portugal
Prior art keywords: hcv; vaccination; envelope protein; protein particles; hcv envelope
Prior art date: 1998-06-24

Application number

PT99929306T

Other languages

English (en)

Inventor

Geert Maertens

Bosman Alfons

Depla Erik

Wijnendaele Van Frans

Original Assignee

Innogenetics Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-24

Filing date

1999-06-23

Publication date

2005-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26152268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1090033(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-06-23 Application filed by Innogenetics Nv filed Critical Innogenetics Nv

2005-05-31 Publication of PT1090033E publication Critical patent/PT1090033E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PT99929306T 1998-06-24 1999-06-23 Particulas de proteinas de envelope do hcv: utilizacao para vacinacao PT1090033E (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP98870142		1998-06-24
EP99870033		1999-02-22
PCT/EP1999/004342 WO1999067285A1 (en)	1998-06-24	1999-06-23	Particles of hcv envelope proteins: use for vaccination

Publications (1)

Publication Number	Publication Date
PT1090033E true PT1090033E (pt)	2005-05-31

Family

ID=26152268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99929306T PT1090033E (pt)	1998-06-24	1999-06-23	Particulas de proteinas de envelope do hcv: utilizacao para vacinacao

Country Status (21)

Country	Link
US (3)	US6635257B1 (pt)
EP (2)	EP1090033B2 (pt)
JP (1)	JP2002518037A (pt)
KR (1)	KR100559096B1 (pt)
CN (1)	CN1313864A (pt)
AT (1)	ATE286067T1 (pt)
AU (1)	AU765940B2 (pt)
BR (1)	BR9911397A (pt)
CA (1)	CA2330526A1 (pt)
DE (1)	DE69922958T3 (pt)
DK (1)	DK1090033T4 (pt)
ES (1)	ES2237115T5 (pt)
HK (1)	HK1037639A1 (pt)
HU (1)	HU227275B1 (pt)
IL (2)	IL140217A0 (pt)
NZ (2)	NZ508797A (pt)
PL (1)	PL201679B1 (pt)
PT (1)	PT1090033E (pt)
RU (1)	RU2247729C2 (pt)
TR (1)	TR200003843T2 (pt)
WO (1)	WO1999067285A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040185061A1 (en) *	1994-07-29	2004-09-23	Innogenetics N.V.	Redox reversible HCV proteins with native-like conformation
NZ508797A (en) *	1998-06-24	2004-02-27	Innogenetics N	Particles of HCV envelope proteins: use for vaccination
US7108855B2 (en)	1998-06-24	2006-09-19	Innogenetics N.V.	Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
PT1221968E (pt) *	1999-10-13	2010-04-16	Novartis Vaccines & Diagnostic	Processo de obtenção de respostas imunes celulares de proteínas
TR200302015T4 (tr) *	2000-06-08	2004-01-21	Intercell Biomedizinische Forschungs-Und Entwicklungs Ag	İmüno-uyarıcı oligodeoksinükleotitler
KR20030057529A (ko) *	2000-09-08	2003-07-04	그리폰 테라퓨틱스, 인코포레이티드	합성 적혈구생성 자극 단백질
US6682909B2 (en) *	2000-09-13	2004-01-27	Hawaii Biotech, Inc.	Immunogenic composition of hepatitis C and methods of use thereof
US7101561B2 (en) *	2000-12-01	2006-09-05	Innogenetics N.V.	Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AR035869A1 (es) *	2001-04-24	2004-07-21	Innogenetics Nv	Proteinas de la envoltura de hcv glicosiladas en la estructura central, un metodo para producir la proteina de envoltura de hcv aislada, una composicion que la comprende, metodo para detectar la presencia de anticuerpos anti-hcv en una muestra, un kit de diagnostico para detectar la presencia de ant
GB0114629D0 (en) *	2001-06-15	2001-08-08	Pfizer Ltd	Method
US20040126395A1 (en) *	2001-12-18	2004-07-01	Geert Maertens	Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU2002361160B2 (en) *	2001-12-18	2008-07-03	Genimmune N.V.	Purified Hepatitis C virus envelope proteins for diagnostic and therapeutic use
FR2839722A1 (fr) *	2002-05-17	2003-11-21	Bio Merieux	Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
JP2004085528A (ja) *	2002-07-05	2004-03-18	Kansai Tlo Kk	拡散定数変化による蛋白質の会合検出方法及び装置
EP1852441B1 (en) *	2002-09-24	2012-03-28	The Burnham Institute	Agents that modulate EPH receptor activity
AU2003268345A1 (en) *	2002-09-24	2004-04-19	The Burnham Institute	Novel agents that modulate eph receptor activity
EP1481985A1 (en) *	2003-05-28	2004-12-01	Innogenetics N.V.	Modified hepatitis C virus (HCV) NS3 for medical treatment
EP1561470A1 (en) *	2003-06-20	2005-08-10	Innogenetics N.V.	HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent
CN1889963A (zh) *	2003-10-10	2007-01-03	宝德杰克特疫苗有限公司	方法
WO2006070028A1 (es) *	2004-12-23	2006-07-06	Berthet Francois Xavier	Composiciones y procedimientos para detectar infección patógena
GB0500020D0 (en)	2005-01-04	2005-02-09	Novartis Ag	Organic compounds
EP1574517A1 (en) *	2004-03-09	2005-09-14	Innogenetics N.V.	HCV E1 comprising specific disulfide bridges
WO2006033012A2 (en) *	2004-09-24	2006-03-30	Pfizer Limited	Method of screening for modulators of hepatitis c virus infection
DE102004057111A1 (de)	2004-11-26	2006-06-01	Niles-Simmons Industrieanlagen Gmbh	Verfahren zum Zwischenbearbeiten von Wellen
CN101146822A (zh)	2005-01-27	2008-03-19	伯纳姆研究所	EphB受体结合肽
WO2007041432A2 (en) *	2005-09-30	2007-04-12	Novartis Vaccines And Diagnostics, Inc.	Cross-neutralization of hcv with recombinant proteins
EP2004685A4 (en) *	2006-03-22	2009-04-29	Genimmune N V	HEPATITIS C VIRUS NEUTRALIZING ANTIBODIES
US20110091495A1 (en) *	2008-04-22	2011-04-21	Rutgers, The State University Of New Jersey	Hcv e2 construct compositions and methods
US9758794B2 (en)	2008-04-22	2017-09-12	Rutgers, The State University Of New Jersey	HCV E2 construct compositions and methods
WO2010052214A2 (en) *	2008-11-05	2010-05-14	Glaxosmithkline Biologicals S.A.	Novel method
BR112013032675A2 (pt) *	2011-06-19	2017-08-08	Vaxine Pty Ltd	composição adjuvante de vacina compreendendo partículas de inulina
JP6567824B2 (ja) *	2011-10-12	2019-08-28	ザトラスティーズオブザユニバーシティオブペンシルバニア	ヒトパピローマウイルスのワクチンおよびその使用方法
RU2510998C2 (ru) *	2012-08-01	2014-04-10	Николай Николаевич Грановский	ВАКЦИНА НА ОСНОВЕ ВИРУСОПОДОБНЫХ ЧАСТИЦ, СОДЕРЖАЩИХ ВСЕ СТРУКТУРНЫЕ АНТИГЕНЫ ВИРУСА ГЕПАТИТА С, И СПОСОБ ЕЕ ПОЛУЧЕНИЯ В ДРОЖЖАХ Hansenula polymorpha
CA2898522A1 (en)	2013-03-12	2014-10-09	The Trustees Of The University Of Pennsylvania	Improved vaccines for human papilloma virus and methods for using the same
CN109963587A (zh)	2016-09-21	2019-07-02	艾伯塔大学理事会	丙型肝炎病毒免疫原性组合物及其使用方法
JP6795468B2 (ja) *	2017-07-14	2020-12-02	ザトラスティーズオブザユニバーシティオブペンシルバニア	ヒトパピローマウイルスのワクチンおよびその使用方法
JP7075130B2 (ja) *	2019-10-25	2022-05-25	ザトラスティーズオブザユニバーシティオブペンシルバニア	ヒトパピローマウイルスのワクチンおよびその使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4395395A (en) *	1979-05-21	1983-07-26	The United States Of America As Represented By The Department Of Health And Human Services	Detection of non-A, non-B hepatitis associated antigen
US6274148B1 (en) *	1990-11-08	2001-08-14	Chiron Corporation	Hepatitis C virus asialoglycoproteins
ATE290592T1 (de) *	1993-11-04	2005-03-15	Innogenetics Nv	Von menschlichen t-zellen immunodominante epitopen des virus der c-hepatitis
JPH09503396A (ja)	1994-07-29	1997-04-08	インノジェネティクス・エヌ・ブイ	診断用及び治療用の精製ｃ型肝炎ウイルスエンベロープ蛋白
DK0804584T3 (da) *	1994-10-21	2002-09-23	Innogenetics Nv	Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
DE69739268D1 (de)	1996-11-08	2009-04-02	Us Gov Health & Human Serv	Herstellung und reinigung von hepatitis c virus-ähnlichen partikeln
DK1471074T3 (da) *	1998-04-17	2008-11-17	Innogenetics Nv	Fremgangsmåder til forbedring af konformationen af proteiner ved hjælp af reduktionsmidler
NZ508797A (en) *	1998-06-24	2004-02-27	Innogenetics N	Particles of HCV envelope proteins: use for vaccination

1999
- 1999-06-23 NZ NZ508797A patent/NZ508797A/xx unknown
- 1999-06-23 RU RU2001101869/13A patent/RU2247729C2/ru not_active IP Right Cessation
- 1999-06-23 US US09/355,040 patent/US6635257B1/en not_active Expired - Fee Related
- 1999-06-23 NZ NZ528952A patent/NZ528952A/en unknown
- 1999-06-23 DE DE69922958T patent/DE69922958T3/de not_active Expired - Fee Related
- 1999-06-23 AT AT99929306T patent/ATE286067T1/de not_active IP Right Cessation
- 1999-06-23 EP EP99929306A patent/EP1090033B2/en not_active Expired - Lifetime
- 1999-06-23 TR TR2000/03843T patent/TR200003843T2/xx unknown
- 1999-06-23 JP JP2000555936A patent/JP2002518037A/ja active Pending
- 1999-06-23 PL PL345018A patent/PL201679B1/pl unknown
- 1999-06-23 IL IL14021799A patent/IL140217A0/xx unknown
- 1999-06-23 EP EP04103826A patent/EP1555270A1/en not_active Withdrawn
- 1999-06-23 WO PCT/EP1999/004342 patent/WO1999067285A1/en active IP Right Grant
- 1999-06-23 CN CN99809890A patent/CN1313864A/zh active Pending
- 1999-06-23 BR BR9911397-0A patent/BR9911397A/pt not_active Application Discontinuation
- 1999-06-23 CA CA002330526A patent/CA2330526A1/en not_active Abandoned
- 1999-06-23 PT PT99929306T patent/PT1090033E/pt unknown
- 1999-06-23 ES ES99929306T patent/ES2237115T5/es not_active Expired - Lifetime
- 1999-06-23 AU AU46152/99A patent/AU765940B2/en not_active Ceased
- 1999-06-23 HU HU0102478A patent/HU227275B1/hu not_active IP Right Cessation
- 1999-06-23 KR KR1020007014761A patent/KR100559096B1/ko not_active IP Right Cessation
- 1999-06-23 DK DK99929306T patent/DK1090033T4/da active
2000
- 2000-12-11 IL IL140217A patent/IL140217A/en not_active IP Right Cessation
2001
- 2001-10-11 HK HK01107139A patent/HK1037639A1/xx not_active IP Right Cessation
2003
- 2003-04-16 US US10/414,219 patent/US20030202987A1/en not_active Abandoned
2006
- 2006-06-02 US US11/445,274 patent/US20060275323A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1037639A1 (en)	2002-02-15
AU765940B2 (en)	2003-10-02
AU4615299A (en)	2000-01-10
KR100559096B1 (ko)	2006-03-15
KR20010053181A (ko)	2001-06-25
HUP0102478A2 (hu)	2001-10-28
WO1999067285A1 (en)	1999-12-29
PL345018A1 (en)	2001-11-19
ATE286067T1 (de)	2005-01-15
NZ508797A (en)	2004-02-27
CN1313864A (zh)	2001-09-19
ES2237115T5 (es)	2008-05-16
NZ528952A (en)	2004-09-24
IL140217A (en)	2009-09-22
EP1555270A1 (en)	2005-07-20
DK1090033T3 (da)	2005-04-25
DE69922958D1 (de)	2005-02-03
ES2237115T3 (es)	2005-07-16
PL201679B1 (pl)	2009-04-30
EP1090033A1 (en)	2001-04-11
DE69922958T2 (de)	2006-03-30
BR9911397A (pt)	2002-01-15
US20030202987A1 (en)	2003-10-30
US20060275323A1 (en)	2006-12-07
US6635257B1 (en)	2003-10-21
TR200003843T2 (tr)	2001-06-21
CA2330526A1 (en)	1999-12-29
JP2002518037A (ja)	2002-06-25
IL140217A0 (en)	2002-02-10
HUP0102478A3 (en)	2004-10-28
DK1090033T4 (da)	2008-03-31
EP1090033B2 (en)	2007-12-19
HU227275B1 (en)	2011-01-28
DE69922958T3 (de)	2008-06-26
RU2247729C2 (ru)	2005-03-10
EP1090033B1 (en)	2004-12-29

Publication	Publication Date	Title
PT1090033E (pt)	2005-05-31	Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
DK0587780T4 (da)	2008-10-13	Smitstof, som forårsager Mystery Swine Disease,vaccinepræparater og diagnostiske sæt
ATE404220T1 (de)	2008-08-15	Rekombinierte pockenvirus-tollwut zusammensetzung und kombinierte zusammensetzungen und deren verwendung
DE60121136D1 (de)	2006-08-10	Proteasom-influenzavirus-impfstoffzusammensetzung
MA24638A1 (fr)	1999-04-01	Vaccin
EP1200109A4 (en)	2005-06-15	USE OF PEPTIDE NUCLEIC ACID COMPOUNDS TO TRIGGER CELLULAR IMMUNE RESPONSES TO HEPATITIS C
DE60133717D1 (de)	2008-06-05	Pharmazeutische zusammensetzung zur immunstimulation und zur zubereitung von impfstoffen enthaltend ein antigen, und als adjuvantien ein immunogenes oligodesoxynukleotid und ein polykationisches polypeptid
DK11789A (da)	1989-07-13	Rekombinante vaccinia-vira
EE200200709A (et)	2004-08-16	Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
AU6160201A (en)	2001-11-26	Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
CY1106152T1 (el)	2011-06-08	Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
CA2505942A1 (en)	2004-06-03	West nile virus vaccine
AU2002220460A1 (en)	2002-05-27	The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
WO2004085633A8 (en)	2007-06-21	A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
AU9215101A (en)	2002-02-25	Vaccines containing ribavirin and methods of use thereof
EP1613345A4 (en)	2007-01-10	COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320
MXPA06013388A (es)	2007-06-19	Vector lentiviral recombinante para la expresion de una proteina flaviviridae y sus aplicaciones como vacuna.
DK1219301T3 (da)	2007-10-22	Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
EP0236977A3 (en)	1989-05-03	Bovine virus diarrhea and hog cholera vaccines
BR0112020A (pt)	2003-05-13	Partìculas tipo vìrus de bvdv
DE60131975D1 (de)	2008-01-31	Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten
DK1423525T3 (da)	2008-12-01	Rekombinant MVA, der kan eksprimere HCV-strukturantigener
WO2003022880A3 (en)	2003-10-09	Synthetic hcv envelope proteins and their use for vaccination
ATE353226T1 (de)	2007-02-15	Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
WO1998042847A3 (de)	1999-03-11	Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung